The effect of positional realignment on dose delivery to the prostate and organs-at-risk for 3DCRT

被引:19
|
作者
Wang, Zhou [1 ]
Rajagopalan, Balu [1 ]
Malhotra, Harish K. [1 ]
Kuettel, Michael R. [1 ]
Podgorsak, Matthew B. [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Radiat Med, Buffalo, NY 14263 USA
关键词
prostate carcinoma; organ motion; ultrasound guidance; 3D conformal radiotherapy; BEAM RADIATION-THERAPY; RADIOTHERAPY; CANCER; MOTION; MARKERS; DISTRIBUTIONS; LOCALIZATION; CARCINOMA;
D O I
10.1016/j.meddos.2006.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we evaluate the impact of daily image-guided patient repositioning on dose delivery to prostate and sensitive organs in the treatment of prostate carcinoma with 3-dimensional conformal radiation therapy (3DCRT). Five patients with substantial ultrasound-documented interfractional prostate motion during their 3DCRT treatment course were selected. Starting with the original treatment plan, 2 additional plans were retrospectively generated for each patient. In one set, organ contours were moved for each fraction, thus simulating positioning with misalignment caused by organ motion if ultrasound guidance were not used. In a second set of plans, the isocenter was shifted, as were the organ contours, simulating realignment based on the ultrasound image. In all cases, the number of planned monitor units was set to those of the original plan. For a given patient, isodose distributions, dose-volume histograms (DVHs), equivalent uniform dose (EUD) for prostate, and generalized equivalent uniform dose (gEUDs) for bladder and rectum were calculated for each fraction and then combined for each shift condition. In all reconstructed plans, the results show no substantial changes in dose coverage of the prostate (< 0.21 % change in EUD) compared to the original plan. However, in some cases with no realignment, a larger volume of the bladder or rectum gets higher dose, with the consequent gEUD for each organ significantly greater compared to the original plan. (C) 2007 American Association of Medical Dosimetrists.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [11] RECTAL AND URYNARY TRACT TOXICITY IN IPOFRACTIONATED 3DCRT PROSTATE CANCER
    Tramacere, Francesco
    Pignatelli, Antonietta
    Devicienti, Salvatore
    Portaluri, Maurizio
    ANTICANCER RESEARCH, 2011, 31 (05) : 1889 - 1889
  • [12] Dose to the contralateral breast using conventional tangential field and 3DCRT
    Zunino, S.
    Garrigo, E.
    Germanier, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81
  • [13] Tracking Target Motion During Delivery of 3DCRT and IMRT Treatment
    Das, K. Maria
    Yoganathan, S.
    Agarwal, A.
    Kumar, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S680 - S681
  • [14] Is heart dose matter more important in SBRT than 3DCRT?
    Kirova, Y.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S73 - S73
  • [15] Dose measurements in a thorax phantom at 3DCRT breast radiation therapy
    Pimenta, Elsa Bifano
    Nogueira, Luciana Batista
    Ribeiro de Campos, Tarcisio Passos
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2021, 26 (02) : 242 - 250
  • [16] Magnetic resonance Spectroscopy Imaging and PSA responses following three-dimensional Conformal external beam radiotherapy (3DCRT) or 3DCRT plus permanent prostate implant (PPI) for intermediate risk prostate cancer
    Pickett, B
    Kurhanewicz, J
    Weinberg, V
    Pouliot, J
    Shinohara, K
    Roach, M
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S142 - S142
  • [17] Impact of interobserver variability and setup uncertainty on dose in organs-at-risk
    Prokic, V.
    Roehner, F.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S893 - S894
  • [18] Initial PSA (iPSA) and Radiation Dose Predict for an Undetectable PSA following 3DCRT or IMRT for Low-intermediate Risk Prostate Cancer
    Sharma, N. K.
    Ruth, K. J.
    Boorjian, S. A.
    Uzzo, R. G.
    Buyyounouski, M. K.
    Horwitz, E. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S313 - S313
  • [19] Planning Study for Comparing 3DCRT and IMRT in Breast Cancer with respect to the Care Possibilities of nearby and distant Risk Organs
    Rennau, H.
    Sebb, S.
    Hildebrandt, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 59 - 59
  • [20] Acute morbidity reduction using 3DCRT for prostate carcinoma: A randomized study
    Koper, PCM
    Stroom, JC
    van Putten, WLJ
    Korevaar, GA
    Heijmen, BJM
    Wijnmaalen, A
    Jansen, PP
    Hanssens, PEJ
    Griep, C
    Krol, ADG
    Samson, MJ
    Levendag, PC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (04): : 727 - 734